[CLSTR]
< Back to situations

[ORGANIZATION]

Panvel

Featured in 7 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

281 clusters · 1054 sources · last updated

Latest: Glp-1 weight management drug consumption in Italy rises 85.7%

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

[ACTIVE] [HEALTH] [BR]

Brazil plans semaglutide integration into SUS

7 clusters · 114 sources · last updated

Latest: Brazil voters support free weight-loss drugs via SUS

The Brazilian Ministry of Health has moved forward with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). To manage the initiative, the Ministry submitted a formal reque

[ACTIVE] [BUSINESS] [BR]

Brazil pharmaceutical industry and market trends

2 clusters · 8 sources · last updated

Latest: Brazil pharmaceutical industry sees growth in domestic production and labor demand

The Brazilian pharmaceutical sector is experiencing shifts in both market sales and industrial production. In August, pharmaceutical market sales growth slowed to 5.9% year-on-year, down from 9.5% in July, with decelerat

Also covered in